跳至主要内容
临床试验/EUCTR2004-004509-11-DE
EUCTR2004-004509-11-DE进行中(未招募)不适用

Efficiency and tolerability of L-Dopa in patients with Hereditary Spastic Paraplegia (HSP)

niversity hospital of the University of Ulm0 个研究点开始时间: 2005年9月6日最近更新:
适应症

试验速览

阶段
不适用
状态
进行中(未招募)
发起方

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional clinical trial of medicinal product

入排标准

性别
All

入选标准

  • 1.) patients (Females and males) aged between 18 to 80 years.
  • 2.) definite noncomplicated spastic paraplegia
  • 3.) ability to understanding the written patients information
  • 4.) ability to cive a written consent
  • 5.) normal electrocardiogramm
  • 6.) females of childbearing age: use of pregnancy preventing arrangements
  • Are the trial subjects under 18? no
  • Number of subjects for this age range:
  • F.1.2 Adults (18-64 years) yes
  • F.1.2.1 Number of subjects for this age range
  • F.1.3 Elderly (>=65 years) yes
  • F.1.3.1 Number of subjects for this age range

排除标准

  • 1.) participation in a clinical trial in the past 12 month using other medicinical pharmaceuticals
  • 2.) contraindications for a therapy with Levodopa: pregnancy, lactation period
  • 3.) Use of Levodopa or dopamine agonists in the past 3 months
  • 4.) any diseases in which the release of functional testing could be impaired
  • 5.) noncomplained patients
  • 6) therapy with phenytoine, papaverine, inhibitors of monoaminooxidase A and B, drugs containing iron sulphit
  • 7) coronary heart disease and cardiac arrhythmias
  • 8) pregnancy, lactation period

研究者

发起方
niversity hospital of the University of Ulm

相似试验